Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Alfredo E, Rodriguez"'
Autor:
Alfredo Matías Rodriguez-Granillo, Leonardo Solórzano, Gilberto Vladimir Pérez-Omaña, Diego Ascarrunz, Hernán Pavlovsky, Reynaldo Gomez-Valerio, Ignacio Bertrán, Federico Flores, Julio Parra, Juan Guiroy, Juan Mieres, Francisco Carvajal, Carlos Fernández-Pereira, Alfredo E. Rodriguez
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundST-elevation myocardial infarction (STEMI) requires revascularization treatment, preferably via primary percutaneous coronary interventions (pPCI). There is a lack of data about contemporary management of STEMI in Latin America.MethodsThis
Externí odkaz:
https://doaj.org/article/1a747e4886e041f8bef89eb2abf893a0
Autor:
Alfredo E. Rodriguez, Carlos Fernandez-Pereira, Juan Ramon Mieres, Alfredo Matias Rodriguez-Granillo
Publikováno v:
Diagnostics, Vol 13, Iss 7, p 1321 (2023)
Despite the introduction of drug-eluting stents (DES) significantly improved the efficacy and safety of percutaneous coronary interventions (PCI), particularly in a high-risk group of patients, the gap between PCI with his competitor’s coronary art
Externí odkaz:
https://doaj.org/article/e7a8e9fd572d4a5f98e05bac8056e16c
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 2016, Iss 10, Pp 195-199 (2016)
Externí odkaz:
https://doaj.org/article/c7aa8c1f961c437bbdc13d655b12aeb1
Autor:
Alfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, Jorge Iravedra, Omar Santaera, Carlos Haiek, Juan Lloberas, Mario Montoya, Elias Sisu, Marcelo Menendez, Hernan Pavlovsky, Alfredo M Rodriguez-Granillo, Juan Mieres, Graciela Romero, Zheng Ming, William Pan, David Antoniucci
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 13 (2019)
The aim of this study was to evaluate 1-year follow-up results in an all “comers” population treated with a new cobalt chromium bare-metal stent (BMS) design. Since August 2016 to March 2017, 201 (9.7% of screening population) consecutive patient
Externí odkaz:
https://doaj.org/article/8ab1cb40574d44ae896e31a5a28c2485
Autor:
Marco, Valgimigli, Enrico, Frigoli, Dik, Heg, Jan, Tijssen, Peter, Jüni, Pascal, Vranckx, Yukio, Ozaki, Marie-Claude, Morice, Bernard, Chevalier, Yoshinobu, Onuma, Stephan, Windecker, Pim A L, Tonino, Marco, Roffi, Maciej, Lesiak, Felix, Mahfoud, Jozef, Bartunek, David, Hildick-Smith, Antonio, Colombo, Goran, Stanković, Andrés, Iñiguez, Carl, Schultz, Ran, Kornowski, Paul J L, Ong, Mirvat, Alasnag, Alfredo E, Rodriguez, Aris, Moschovitis, Peep, Laanmets, Michael, Donahue, Sergio, Leonardi, Pieter C, Smits, Nguyen Ngoc, Quang
Publikováno v:
New England journal of medicine, 385(18), 1643-1655. Massachussetts Medical Society
The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.One month after they had undergone implantation of a biodegradable-polymer sirolimus-e
Autor:
Ran Kornowski, Mirvat Alasnag, Carl Schultz, Dik Heg, David Hildick-Smith, Peter Jüni, Bernard Chevalier, Andrés Iñiguez, Yoshinobu Onuma, Felix Mahfoud, Master Dapt investigators, Marco Roffi, Marie-Claude Morice, Goran Stankovic, Antonio Colombo, Enrico Frigoli, Alfredo E. Rodriguez, Aris Moschovitis, Maciej Lesiak, Stephan Windecker, Pim A.L. Tonino, Paul Jau Lueng Ong, Pieter C. Smits, Marco Valgimigli, Pascal Vranckx, Jozef Bartunek, Yukio Ozaki, Jan G.P. Tijssen, Peep Laanmets
Publikováno v:
Smits, Pieter C; Frigoli, Enrico; Tijssen, Jan; Jüni, Peter; Vranckx, Pascal; Ozaki, Yukio; Morice, Marie-Claude; Chevalier, Bernard; Onuma, Yoshinobu; Windecker, Stephan; Tonino, Pim A L; Roffi, Marco; Lesiak, Maciej; Mahfoud, Felix; Bartunek, Jozef; Hildick-Smith, David; Colombo, Antonio; Stankovic, Goran; Iñiguez, Andres; Schultz, Carl; ... (2021). Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial. Circulation, 144(15), pp. 1196-1211. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.121.056680
Circulation
Circulation, 144(15), 1196-1211. Lippincott Williams and Wilkins
Circulation
Circulation, 144(15), 1196-1211. Lippincott Williams and Wilkins
Supplemental Digital Content is available in the text.
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear. Methods:
Background: The optimal duration of antiplatelet therapy (APT) in patients at high bleeding risk with or without oral anticoagulation (OAC) after coronary stenting remains unclear. Methods:
Publikováno v:
European heart journal open. 2(2)
Autor:
Anniina Färkkilä, Alfredo E. Rodriguez, Doga Gulhan, Jean-Bernard Lazaro, Sandra Ramos, Peter J. Park, Connor Clairmont, Julieta Dominguez, Jaana Oikkonen, Huy V. Nguyen, Lisa A. Moreau, Fernando Pérez-Villatoro, Sara Frías, Caitlin E. Mills, Alan D. D'Andrea, Sampsa Hautaniemi, Peter K. Sorger, Jia Zhou
Publikováno v:
Cancer Research. 81:2774-2787
Homologous recombination (HR)-deficient cancers are sensitive to poly-ADP ribose polymerase inhibitors (PARPi), which have shown clinical efficacy in the treatment of high-grade serous cancers (HGSC). However, the majority of patients will relapse, a
Publikováno v:
Future Cardiology. 16:711-723
Percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) in pre-drug-eluting stents (DESs) era, randomized trials and meta-analysis showed that the extension of coronary artery disease was not associated with a better survival
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 10 (2016)
Randomized clinical trials (RCTs) with first- and second-generation drug-eluting stents (DESs) confirmed the superiority of coronary artery bypass surgery (CABG) in patients with multiple vessel disease. In spite of different DES designs, investigato
Externí odkaz:
https://doaj.org/article/a12c4751709448c688abb4bce8623266